[JANX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
10-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 19.82%
YoY- 16.07%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 2,517 1,057 2,048 2,845 1,813 2,365 1,589 35.84%
PBT -11,568 -17,508 -17,459 -16,065 -16,696 -16,888 -13,410 -9.37%
Tax -500 349 -453 -4,805 -2,652 -373 -264 53.01%
NP -11,568 -17,508 -17,459 -11,260 -14,044 -16,515 -13,146 -8.16%
Tax Rate - - - - - - - -
Total Cost 14,085 18,565 19,507 14,105 15,857 18,880 14,735 -2.96%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -459.59 -1,656.39 -852.49 -395.78 -774.63 -698.31 -827.31 -32.39%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.25 -0.42 -0.42 -0.27 -0.34 -0.40 -0.32 -15.16%
EPS Diluted -0.25 -0.42 -0.42 -0.27 -0.34 -0.40 -0.32 -15.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.